Global Small Molecule Targeted Drugs for Allergic Diseases Market Growth (Status and Outlook) 2026-2032
The global Small Molecule Targeted Drugs for Allergic Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
United States market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Small Molecule Targeted Drugs for Allergic Diseases players cover AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Small Molecule Targeted Drugs for Allergic Diseases Industry Forecast” looks at past sales and reviews total world Small Molecule Targeted Drugs for Allergic Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Molecule Targeted Drugs for Allergic Diseases sales for 2026 through 2032. With Small Molecule Targeted Drugs for Allergic Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Targeted Drugs for Allergic Diseases industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Targeted Drugs for Allergic Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Targeted Drugs for Allergic Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule Targeted Drugs for Allergic Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Targeted Drugs for Allergic Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Targeted Drugs for Allergic Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Targeted Drugs for Allergic Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
United States market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Small Molecule Targeted Drugs for Allergic Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Small Molecule Targeted Drugs for Allergic Diseases players cover AbbVie, Pfizer, Novartis, Eli Lilly and Company, LEO Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Small Molecule Targeted Drugs for Allergic Diseases Industry Forecast” looks at past sales and reviews total world Small Molecule Targeted Drugs for Allergic Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Molecule Targeted Drugs for Allergic Diseases sales for 2026 through 2032. With Small Molecule Targeted Drugs for Allergic Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Targeted Drugs for Allergic Diseases industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Targeted Drugs for Allergic Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Targeted Drugs for Allergic Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule Targeted Drugs for Allergic Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Targeted Drugs for Allergic Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Targeted Drugs for Allergic Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Targeted Drugs for Allergic Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
- JAK
- TYK2
- Atopic Dermatitis
- Asthma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Pfizer
- Novartis
- Eli Lilly and Company
- LEO Pharma
- AstraZeneca
- Incyte
- Jiangsu Hengrui Pharmaceuticals
- Suzhou Zelgen Biopharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size (2021-2032)
2.1.2 Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Molecule Targeted Drugs for Allergic Diseases by Country/Region (2021, 2025 & 2032)
2.2 Small Molecule Targeted Drugs for Allergic Diseases Segment by Type
2.2.1 JAK
2.2.2 TYK2
2.2.3 Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type
2.2.3.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
2.3 Small Molecule Targeted Drugs for Allergic Diseases Segment by Application
2.3.1 Atopic Dermatitis
2.3.2 Asthma
2.3.3 Others
2.3.4 Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application
2.3.4.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
3 SMALL MOLECULE TARGETED DRUGS FOR ALLERGIC DISEASES MARKET SIZE BY PLAYER
3.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Player
3.1.1 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Player (2021-2026)
3.1.2 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2021-2026)
3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE TARGETED DRUGS FOR ALLERGIC DISEASES BY REGION
4.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026)
4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
4.4 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
4.5 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026)
5.2 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
5.3 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026)
6.2 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
6.3 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026)
7.2 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
7.3 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases by Region (2021-2026)
8.2 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL MOLECULE TARGETED DRUGS FOR ALLERGIC DISEASES MARKET FORECAST
10.1 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.1.1 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.1.2 Americas Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.1.3 APAC Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.1.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.1.5 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2 Americas Small Molecule Targeted Drugs for Allergic Diseases Forecast by Country (2027-2032)
10.2.1 United States Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2.2 Canada Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2.3 Mexico Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2.4 Brazil Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3 APAC Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.3.1 China Small Molecule Targeted Drugs for Allergic Diseases Market Forecast
10.3.2 Japan Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.3 Korea Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.4 Southeast Asia Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.5 India Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.6 Australia Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.2 France Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.3 UK Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.4 Italy Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.5 Russia Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5.2 South Africa Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5.3 Israel Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5.4 Turkey Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.6 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Type (2027-2032)
10.7 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.1.3 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.2.3 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.3.3 Novartis Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Information
11.4.2 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.4.3 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Eli Lilly and Company Main Business Overview
11.4.5 Eli Lilly and Company Latest Developments
11.5 LEO Pharma
11.5.1 LEO Pharma Company Information
11.5.2 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.5.3 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 LEO Pharma Main Business Overview
11.5.5 LEO Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.6.3 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Incyte
11.7.1 Incyte Company Information
11.7.2 Incyte Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.7.3 Incyte Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Incyte Main Business Overview
11.7.5 Incyte Latest Developments
11.8 Jiangsu Hengrui Pharmaceuticals
11.8.1 Jiangsu Hengrui Pharmaceuticals Company Information
11.8.2 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.8.3 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
11.8.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
11.9 Suzhou Zelgen Biopharmaceuticals
11.9.1 Suzhou Zelgen Biopharmaceuticals Company Information
11.9.2 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.9.3 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Suzhou Zelgen Biopharmaceuticals Main Business Overview
11.9.5 Suzhou Zelgen Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size (2021-2032)
2.1.2 Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Molecule Targeted Drugs for Allergic Diseases by Country/Region (2021, 2025 & 2032)
2.2 Small Molecule Targeted Drugs for Allergic Diseases Segment by Type
2.2.1 JAK
2.2.2 TYK2
2.2.3 Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type
2.2.3.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
2.3 Small Molecule Targeted Drugs for Allergic Diseases Segment by Application
2.3.1 Atopic Dermatitis
2.3.2 Asthma
2.3.3 Others
2.3.4 Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application
2.3.4.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
3 SMALL MOLECULE TARGETED DRUGS FOR ALLERGIC DISEASES MARKET SIZE BY PLAYER
3.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Player
3.1.1 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Player (2021-2026)
3.1.2 Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2021-2026)
3.2 Global Small Molecule Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE TARGETED DRUGS FOR ALLERGIC DISEASES BY REGION
4.1 Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026)
4.2 Global Small Molecule Targeted Drugs for Allergic Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
4.4 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
4.5 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026)
5.2 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
5.3 Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026)
6.2 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
6.3 APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026)
7.2 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
7.3 Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases by Region (2021-2026)
8.2 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL MOLECULE TARGETED DRUGS FOR ALLERGIC DISEASES MARKET FORECAST
10.1 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.1.1 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.1.2 Americas Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.1.3 APAC Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.1.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.1.5 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2 Americas Small Molecule Targeted Drugs for Allergic Diseases Forecast by Country (2027-2032)
10.2.1 United States Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2.2 Canada Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2.3 Mexico Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.2.4 Brazil Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3 APAC Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.3.1 China Small Molecule Targeted Drugs for Allergic Diseases Market Forecast
10.3.2 Japan Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.3 Korea Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.4 Southeast Asia Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.5 India Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.3.6 Australia Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4 Europe Small Molecule Targeted Drugs for Allergic Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.2 France Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.3 UK Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.4 Italy Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.4.5 Russia Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5 Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5.2 South Africa Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5.3 Israel Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.5.4 Turkey Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
10.6 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Type (2027-2032)
10.7 Global Small Molecule Targeted Drugs for Allergic Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Molecule Targeted Drugs for Allergic Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.1.3 AbbVie Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.2.3 Pfizer Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.3.3 Novartis Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Information
11.4.2 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.4.3 Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Eli Lilly and Company Main Business Overview
11.4.5 Eli Lilly and Company Latest Developments
11.5 LEO Pharma
11.5.1 LEO Pharma Company Information
11.5.2 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.5.3 LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 LEO Pharma Main Business Overview
11.5.5 LEO Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.6.3 AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Incyte
11.7.1 Incyte Company Information
11.7.2 Incyte Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.7.3 Incyte Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Incyte Main Business Overview
11.7.5 Incyte Latest Developments
11.8 Jiangsu Hengrui Pharmaceuticals
11.8.1 Jiangsu Hengrui Pharmaceuticals Company Information
11.8.2 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.8.3 Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
11.8.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
11.9 Suzhou Zelgen Biopharmaceuticals
11.9.1 Suzhou Zelgen Biopharmaceuticals Company Information
11.9.2 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
11.9.3 Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Suzhou Zelgen Biopharmaceuticals Main Business Overview
11.9.5 Suzhou Zelgen Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Molecule Targeted Drugs for Allergic Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of JAK
Table 4. Major Players of TYK2
Table 5. Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Table 8. Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Table 11. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2021-2026)
Table 13. Small Molecule Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
Table 14. Small Molecule Targeted Drugs for Allergic Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Table 19. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2021-2026)
Table 23. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Table 25. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Table 27. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Table 29. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2021-2026)
Table 33. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Small Molecule Targeted Drugs for Allergic Diseases
Table 39. Key Market Challenges & Risks of Small Molecule Targeted Drugs for Allergic Diseases
Table 40. Key Industry Trends of Small Molecule Targeted Drugs for Allergic Diseases
Table 41. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. AbbVie Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 46. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 47. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. AbbVie Main Business
Table 49. AbbVie Latest Developments
Table 50. Pfizer Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 51. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 52. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Pfizer Main Business
Table 54. Pfizer Latest Developments
Table 55. Novartis Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 56. Novartis Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 57. Novartis Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Eli Lilly and Company Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 61. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 62. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Eli Lilly and Company Main Business
Table 64. Eli Lilly and Company Latest Developments
Table 65. LEO Pharma Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 66. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 67. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. LEO Pharma Main Business
Table 69. LEO Pharma Latest Developments
Table 70. AstraZeneca Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 71. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 72. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Latest Developments
Table 75. Incyte Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 76. Incyte Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 77. Incyte Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Incyte Main Business
Table 79. Incyte Latest Developments
Table 80. Jiangsu Hengrui Pharmaceuticals Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 81. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 82. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Jiangsu Hengrui Pharmaceuticals Main Business
Table 84. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 85. Suzhou Zelgen Biopharmaceuticals Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 86. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 87. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Suzhou Zelgen Biopharmaceuticals Main Business
Table 89. Suzhou Zelgen Biopharmaceuticals Latest Developments
Table 1. Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Molecule Targeted Drugs for Allergic Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of JAK
Table 4. Major Players of TYK2
Table 5. Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Table 8. Small Molecule Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Table 11. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2021-2026)
Table 13. Small Molecule Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
Table 14. Small Molecule Targeted Drugs for Allergic Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Table 19. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2021-2026)
Table 23. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Table 25. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Table 27. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Table 29. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2021-2026)
Table 33. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Small Molecule Targeted Drugs for Allergic Diseases
Table 39. Key Market Challenges & Risks of Small Molecule Targeted Drugs for Allergic Diseases
Table 40. Key Industry Trends of Small Molecule Targeted Drugs for Allergic Diseases
Table 41. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. AbbVie Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 46. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 47. AbbVie Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. AbbVie Main Business
Table 49. AbbVie Latest Developments
Table 50. Pfizer Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 51. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 52. Pfizer Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Pfizer Main Business
Table 54. Pfizer Latest Developments
Table 55. Novartis Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 56. Novartis Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 57. Novartis Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Eli Lilly and Company Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 61. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 62. Eli Lilly and Company Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Eli Lilly and Company Main Business
Table 64. Eli Lilly and Company Latest Developments
Table 65. LEO Pharma Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 66. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 67. LEO Pharma Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. LEO Pharma Main Business
Table 69. LEO Pharma Latest Developments
Table 70. AstraZeneca Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 71. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 72. AstraZeneca Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Latest Developments
Table 75. Incyte Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 76. Incyte Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 77. Incyte Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Incyte Main Business
Table 79. Incyte Latest Developments
Table 80. Jiangsu Hengrui Pharmaceuticals Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 81. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 82. Jiangsu Hengrui Pharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Jiangsu Hengrui Pharmaceuticals Main Business
Table 84. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 85. Suzhou Zelgen Biopharmaceuticals Details, Company Type, Small Molecule Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 86. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Product Offered
Table 87. Suzhou Zelgen Biopharmaceuticals Small Molecule Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Suzhou Zelgen Biopharmaceuticals Main Business
Table 89. Suzhou Zelgen Biopharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Small Molecule Targeted Drugs for Allergic Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Molecule Targeted Drugs for Allergic Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Molecule Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2025)
Figure 8. Small Molecule Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type in 2025
Figure 10. Small Molecule Targeted Drugs for Allergic Diseases in Atopic Dermatitis
Figure 11. Global Small Molecule Targeted Drugs for Allergic Diseases Market: Atopic Dermatitis (2021-2026) & ($ millions)
Figure 12. Small Molecule Targeted Drugs for Allergic Diseases in Asthma
Figure 13. Global Small Molecule Targeted Drugs for Allergic Diseases Market: Asthma (2021-2026) & ($ millions)
Figure 14. Small Molecule Targeted Drugs for Allergic Diseases in Others
Figure 15. Global Small Molecule Targeted Drugs for Allergic Diseases Market: Others (2021-2026) & ($ millions)
Figure 16. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application in 2025
Figure 17. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Player in 2025
Figure 18. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Figure 19. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 20. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 21. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 23. Americas Small Molecule Targeted Drugs for Allergic Diseases Value Market Share by Country in 2025
Figure 24. United States Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region in 2025
Figure 29. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Figure 30. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Figure 31. China Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. India Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Country in 2025
Figure 38. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Figure 39. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Figure 40. Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 41. France Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 54. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 55. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 57. United States Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 58. Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 59. Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 60. Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 61. China Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 62. Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 63. Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 65. India Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 66. Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 67. Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 68. France Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 69. UK Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 70. Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 71. Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 72. Egypt Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 73. South Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 74. Israel Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 75. Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 76. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 1. Small Molecule Targeted Drugs for Allergic Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Molecule Targeted Drugs for Allergic Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Molecule Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2025)
Figure 8. Small Molecule Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type in 2025
Figure 10. Small Molecule Targeted Drugs for Allergic Diseases in Atopic Dermatitis
Figure 11. Global Small Molecule Targeted Drugs for Allergic Diseases Market: Atopic Dermatitis (2021-2026) & ($ millions)
Figure 12. Small Molecule Targeted Drugs for Allergic Diseases in Asthma
Figure 13. Global Small Molecule Targeted Drugs for Allergic Diseases Market: Asthma (2021-2026) & ($ millions)
Figure 14. Small Molecule Targeted Drugs for Allergic Diseases in Others
Figure 15. Global Small Molecule Targeted Drugs for Allergic Diseases Market: Others (2021-2026) & ($ millions)
Figure 16. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application in 2025
Figure 17. Global Small Molecule Targeted Drugs for Allergic Diseases Revenue Market Share by Player in 2025
Figure 18. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Figure 19. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 20. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 21. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size 2021-2026 ($ millions)
Figure 23. Americas Small Molecule Targeted Drugs for Allergic Diseases Value Market Share by Country in 2025
Figure 24. United States Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region in 2025
Figure 29. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Figure 30. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Figure 31. China Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. India Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Country in 2025
Figure 38. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Figure 39. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Figure 40. Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 41. France Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Small Molecule Targeted Drugs for Allergic Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 54. APAC Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 55. Europe Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 57. United States Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 58. Canada Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 59. Mexico Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 60. Brazil Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 61. China Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 62. Japan Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 63. Korea Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 65. India Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 66. Australia Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 67. Germany Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 68. France Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 69. UK Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 70. Italy Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 71. Russia Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 72. Egypt Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 73. South Africa Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 74. Israel Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 75. Turkey Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
Figure 76. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Small Molecule Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Small Molecule Targeted Drugs for Allergic Diseases Market Size 2027-2032 ($ millions)
